Erlotinib hydrochloride
Erlotinib hydrochloride | |
---|---|
Term | Erlotinib hydrochloride |
Short definition | erlotinib hydrochloride (er-LOH-tih-nib HY-droh-KLOR-ide) A drug used alone to treat certain types of non-small cell lung cancer and together with gemcitabine hydrochloride to treat certain types of pancreatic cancer is used. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
erlotinib hydrochloride - (pronounced) (er-LOH-tih-nib HY-droh-KLOR-ide) A drug used alone to treat certain types of non-small cell lung cancer and together with gemcitabine hydrochloride to treat certain types of pancreatic cancer is used. It is also being studied in the treatment of other types of cancer. Erlotinib hydrochloride blocks a protein called EGFR, which can help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called CP-358. 774, OSI-774 and Tarceva
External links
- Medical encyclopedia article on Erlotinib hydrochloride
- Wikipedia's article - Erlotinib hydrochloride
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski